Related Experiment Video
Updated: Feb 12, 2026

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
Relation of Testosterone Levels to Mortality in Men With Heart Failure
Akiomi Yoshihisa1, Satoshi Suzuki1, Yu Sato1
1Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Insights
Low testosterone levels in men with heart failure are linked to increased mortality, reduced exercise capacity, and myocardial damage. This study highlights testosterone
Area of Science:
- Cardiology
- Endocrinology
- Internal Medicine
Background:
- Heart failure (HF) is a complex syndrome with significant morbidity and mortality.
- The role of hormonal imbalances, particularly testosterone deficiency, in HF prognosis is an area of ongoing research.
- Understanding the relationship between testosterone levels and cardiac function, damage, and exercise capacity is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the impact of serum total testosterone (TT) levels on the prognosis of heart failure (HF) in men.
- To examine the association between TT levels and underlying cardiac function, myocardial damage, and exercise capacity in HF patients.
- To identify TT as a potential independent predictor of all-cause mortality in men with HF.
Main Methods:
- Analysis of 618 male HF patients, stratified into four quartiles based on serum total testosterone (TT) levels.
- Kaplan-Meier survival analysis and multivariable Cox proportional hazard analysis to assess all-cause mortality.
- Comparison of echocardiography parameters, cardiopulmonary exercise testing (peak VO2), B-type natriuretic peptide, and cardiac troponin I levels across TT quartiles.
Main Results:
- All-cause mortality progressively increased from the highest to the lowest TT quartile.
- Low serum TT (fourth quartile) was associated with significantly higher levels of cardiac troponin I (myocardial damage) and lower peak VO2 (exercise capacity) compared to the highest TT quartile.
- Total testosterone (TT) was identified as an independent predictor of all-cause mortality in men with HF (HR 0.929, p=0.042).
Conclusions:
- Decreased serum testosterone levels are significantly associated with adverse outcomes in men with heart failure.
- Lower testosterone is linked to increased myocardial damage and reduced exercise capacity, contributing to higher mortality.
- Serum testosterone levels may serve as a valuable prognostic marker in male patients with HF.
Abstract:
We aimed to investigate the impact of testosterone on the prognosis of heart failure (HF), as well as the underlying cardiac function, cardiac damage, and exercise capacity. We analyzed consecutive 618 men with HF (age 65.9 years). These patients were divided into quartiles based on their serum levels of total testosterone (TT): first (TT > 631 ng/dl, n = 154), second (462 < TT ≤ 631 ng/dl, n = 155), third (300 < TT ≤ 462 ng/dl, n = 156), and fourth (TT ≤ 300 ng/dl, n = 153) quartiles. In the Kaplan-Meier analysis (mean 1,281 days), all-cause mortality progressively increased throughout from the first to the fourth groups. In the multivariable Cox proportional hazard analysis, TT was found to be an independent predictor of all-cause mortality (hazard ratio 0.929, p = 0.042). In addition, we compared the parameters of echocardiography and cardiopulmonary exercise testing, as well as levels of B-type natriuretic peptide and cardiac troponin I, among the 4 groups. Left ventricular ejection fraction and B-type natriuretic peptide did not differ among the groups. In contrast, the fourth quartile, compared with the first, second, and third groups, had higher levels of troponin I and lower peak VO2 (p <0.05, respectively). Decreased serum testosterone is associated with myocardial damage, lower exercise capacity, and higher mortality in men with HF.
More Related Videos
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management

